Renal function Multi-parametric quantitative MRI (qMRI) Arterial spin labeling (ASL) Blood oxygen level dependent (BOLD) T1rho MRI Lupus nephritis (LN) Purpose: To identify potential biomarkers of the renal impairment in lupus nephritis using a multi-parametric renal quantitative MRI (qMRI) protocol including diffusion weighted imaging (DWI), blood oxygen level dependent (BOLD), arterial spin labeling (ASL) and T1rho MRI between a cohort of healthy volunteers and lupus nephritis (LN) patients. Materials and methods: The renal qMRI protocol was performed twice with repositioning in between on 10 LN patients and 10 matched controls at 1.5 T. Navigator-gated and breath-hold acquisitions followed by non-rigid image registration were used to control respiratory motion. The repeatability of the 4 MRI modalities was evaluated with the intra-class correlation coefficient (ICC) and within-subject coefficient of variation (wsCV). Unpaired t-test and stepwise logistic regression were carried out to evaluate qMRI parameters between the LN and control groups. Results: The reproducibility of the 4 qMRI modalities ranged from moderate to good (ICC = 0.4-0.91, wsCV ≤ 12%) with a few exceptions. T1rho MRI and ASL renal blood flow (RBF) demonstrated significant differences between the LN and control groups. Stepwise logistic regression yielded only one significant parameter (medullar T1rho) in differentiating LN from control groups with 95% accuracy. Conclusion: A reasonable degree of test-retest repeatability and accuracy of a multi-parametric renal qMRI protocol has been demonstrated in healthy volunteers and LN subjects. T1rho and ASL RBF are promising imaging biomarkers of LN.
Lupus nephritis (LN) affects over half of all patients with systemic lupus erythematosus (SLE), even those without clinical manifestations of renal disease. This condition increases mortality and morbidity rates among patients due to, among other reasons, the risk of chronic kidney disease with the need for renal transplant in approximately 25% of cases. Lupus nephritis is mostly diagnosed in women in their thirties and is the primary cause of systemic disease with secondary renal involvement [1] . Available clinical endpoints in LN to assess response to treatment have limited utility, as they may not directly reflect renal histopathological features that have been associated with poor prognosis [2] . Histopathological renal inflammatory activity and/or damage may persist despite clinically silent disease after treatment. Furthermore, histological renal damage may take a long time to become clinically evident as assessed by currently available clinical biomarkers (e.g., doubling serum creatinine).
Recent Food and Drug Administration (FDA) guidance for the development of treatments for LN suggests that, when feasible, renal biopsies should be obtained at the end of a trial evaluating renal response or remission to demonstrate that an improved renal response corresponds to a histologic improvement, including effects on the percent of sclerosed glomeruli [3] . However, the adoption of repeat biopsy in a clinical trial setting has been and it is expected to continue to be very low. Renal imaging may provide important markers of kidney diseases through the evaluation of the morphology, function and metabolism of the kidney. During recent years, several magnetic resonance imaging (MRI) techniques have shown promises as imaging biomarkers for kidney diseases [4] . These MRI techniques include diffusion weighted imaging (DWI), bloodoxygenation-level dependent (BOLD) imaging, perfusion imaging with arterial spin labeling (ASL), and T1rho MRI. DWI measures apparent diffusion coefficient (ADC) values and quantifies the combined effects of blood microcirculation and Brownian motion of water molecules within the interstitial space [5, 6] . DWI studies on kidney diseases revealed that patients with renal failure have significantly lower ADC values in the cortex and medulla than normal healthy volunteers [7] . More recently, this technique was successfully used to demonstrate a correlation between ADC reductions and renal fibrosis in ligated kidneys in a mouse unilateral urethral obstruction model of interstitial fibrosis [8] . BOLD MRI noninvasively assesses tissue oxygen bioavailability by measuring relative changes in deoxyhemoglobin, an endogenous paramagnetic contrast agent. Quantitative BOLD MRI R2* values have been demonstrated experimentally to correlate to acute and transient changes in oxygenation levels in the renal cortex and medulla [9, 10] . Additionally, the capability of BOLD MRI to evaluate chronic, progressive, parenchymal hypoxia in renal allografts has been reported [11] .
Given that subjects with renal dysfunction are generally not suitable for contrast agents, ASL offers an appealing approach for renal perfusion imaging by utilizing magnetically labeled arterial blood water as an endogenous tracer. With recent technical developments to effectively control respiratory motion, ASL MRI approaches have been shown to provide reliable and quantitative kidney perfusion measurements in clinical settings [12, 13] . T1rho MRI is another emerging MRI technique that is sensitive to the presence of macromolecules (such as collagen and proteoglycan [14] ). A preclinical study in a rat biliary duct ligation (BDL) model demonstrated that T1rho imaging detected liver fibrosis in BDL rats and that the degree of fibrosis correlated with the degree of increase in T1rho measurements [15] .
All four MRI techniques, as described above, are non-contrast and quantitative, and can be applied longitudinally to monitor disease progression and/or treatment effects. The combination of the four techniques is likely to provide a multi-modality evaluation of renal function, and may provide more accurate characterization or staging of kidney diseases such as LN than each individual technique alone. The primary aim of the present study was to develop a multiparametric renal qMRI protocol and evaluate its test-retest repeatability in a cohort of LN patients and healthy normal volunteers (HN). The secondary aim was to evaluate the clinical utility of the multi-parametric renal quantitative MRI protocol in differentiating LN patients from HN subjects.
Material and methods

Subjects recruitment
This study received institutional review board approval and informed consent was obtained from all subjects. Ten healthy volunteers (age = 29.4 ± 5.0 years, 8 F) and 10 biopsy-confirmed LN patients (age = 31.8 ± 6.2 years, 8 F) were recruited in this study. All subjects underwent a screening visit within 7 days prior to MRI to determine their eligibility for the study. The general inclusion criteria were: 1) age 18-60 years and 2) ability to understand study procedures and provide informed consent. The general exclusion criteria were: 1) contraindication for MRI or claustrophobia and 2) positive pregnancy test. Normal healthy volunteers were deemed healthy by the Investigator, based on the following assessments at screening: physical examination, medical history, vital signs, and clinical laboratory measurements of blood and urine samples (Covance Inc., Princeton, NJ, USA). Healthy volunteers with the following conditions were excluded: 1) receiving treatment with any prescription medication within 2 weeks before screening with the exception of contraceptives for women of childbearing potential, and 2) clinically significant abnormal clinical laboratory test values at Screening. LN patients had a documented diagnosis of SLE according to current American College of Rheumatology (ACR) criteria and a documented renal biopsy with diagnosis of LN. Exclusion criteria for the LN group included: 1) history of renal transplant and 2) subjects with uncontrolled diabetes or other condition that may result in significant renal disease.
MRI scanning and protocol
MRI experiments were performed on a 1.5 Tesla Siemens Avanto MR scanner (Erlangen, Germany), using an 8-channel flexible body array and the spinal array coil as the receiver. Each subject underwent two consecutive MRI sessions, with complete repositioning in between, in order to assess the reproducibility of the renal multi-parametric qMRI protocol. Each MRI session began with conventional 3D T1 weighted (T1w) volumetric interpolated breath-hold (VIBE, TR/TE = 4.5/1.6 ms, resolution = 1.1 × 1.1 × 2.5 mm ) that were used as anatomical localizers for both the kidneys and renal arteries. The renal qMRI protocol consisted of 4 quantitative MRI sequences including DWI, BOLD, T1rho and pseudocontinuous ASL (pCASL). In addition, phase-contrast (PC) MRI was performed to estimate the global renal blood flow (RBF) for comparison with renal perfusion measurements using pCASL. The duration of each MRI session ranged from 30 to 45 min, and the total duration of 2 repeated MRI sessions was less than 1.5 hr. Table 1 lists the imaging parameters of the 4 sequences for the renal quantitative MRI protocol along with PC MRI. In order to balance the burden of breath holding and fast scans, two strategies were applied for controlling respiratory motion: 1) breath-holds (BH) that lasted no longer than 18 s each and performed at the end of expiration for BOLD, T1rho and PC MRI scans; and 2) navigator gated free-breathing (NavFB) acquisitions that were matched to be acquired during the end-expiration phase for DWI and pCASL scans. The navigator used a pencil-beam spin echo placed on the right diaphragm at the liver-lung interface with a ±5 mm acceptance range. DWI was performed using the product DW single-shot spin-echo EPI sequence with 7 b-values ranging from 0 to 700 s/mm 2 . Based on our pilot study and literature [16] , the DWI scan was repeated twice which were averaged to improve the reliability of exponential fitting. BOLD MRI was acquired using the product multi-echo gradient echo (GRE) sequence in 3 concatenated breath-holds, with 12 incremental TEs between 2.2 and 43.7 ms that were in-phase for water and fat signals. For both DWI and BOLD MRI, 10 coronal slices were acquired for a complete coverage of the kidneys.
Both T1rho [14] and pCASL [17] MRI used custom sequences developed in-house. A single oblique-coronal slice through both kidneys was imaged using a single-shot balanced steady-state free precession (bSSFP) sequence. The imaging slice was prescribed to be parallel to the descending aorta to avoid artifacts related to pulsatile aortic flow. A pre-saturation pulse was applied on the imaging slice at the beginning of each TR for both T1rho and pCASL scans. During T1rho preparation, the previously reported approach using a continuous train of spin-locking hard pulses interleaved with adiabatic refocusing pulses (N = 4) [14, 18] was used to minimize artifacts associated with B0 (background magnetic field) and B1 (RF transmission) imperfection. Spin-locking hard pulses used a B1 magnitude of 10 μT, which is positioned at a smooth and stable portion of the renal tissue T1rho dispersion curve. A total of 4 repetitions with incremental spin lock times (TSL = 10, 30, 50, 70 ms) enabled T1rho quantification. The axial pCASL labeling plane was placed approximately 10 cm above the center of kidneys (Fig. 1) . Detailed parameters for T1rho and pCASL sequences can be found in Refs. [14, 17, 19] . PC-MRI was performed in an obliquesagittal plane placed perpendicular to the renal artery of each kidney respectively, based on T1w and T2w images. A pulse-oxymetry was used to synchronize the subject's cardiac cycle, resulting in a temporal resolution of 60 ms for PC MRI scans.
Image post-processing
Raw DICOM images of the 4 sequences were transferred and processed off-line using custom pipelines including ANTs (Advanced Normalization Tools, http://picsl.upenn.edu/software/ants/), OsiriX (Osirix foundation, Geneva, Switzerland) and Matlab (Mathworks, Natick, MA). To minimize residual motion (particularly in navigatorgated scans), a non-rigid body motion correction was applied by maximizing the cross-correlation between image frames using symmetric diffeomorphic image registration by the ANTs software [20, 21] . Afterwards, all images were brought in Osirix for image quality assessment, parameter quantification and region-of-interest (ROI) analyses. Quantitative T2* values were fitted from the BOLD scan using the OsiriX T2 Fit Map plugin. For DWI, ADC values were fitted using the OsiriX ADCmap plugin to generate ADC maps, using b values ≥ 200 s/mm 2 to minimize the effect of microvascular flow on tissue ADC values [22, 5, 6] . RBF was calculated using custom program in Matlab (Mathworks, Natick, MA) in units of mL/100 g/min using the pCASL scan [23] :
where ΔM is the mean difference signal, M C is the mean control magnetization, α is the labeling efficiency (0.74 based on a flow phantom study), λ is the blood/tissue water partition coefficient (0.9 g/mL), T 1b (1.3 s at 1.5 T) is the longitudinal relaxation time of water in the blood, τ (2 s) is the labeling duration, and w (1.2 s) is the post-labeling delay. Eq. (1) assumes that the labeled blood stays in the vasculature rather than completely exchanging into the tissue compartment, which may lead to underestimation of perfusion, since kidney tissue T1 (~1 s) is shorter than blood T1 (1.3 s). Nevertheless, our simulation indicated that this perfusion underestimation is only 5% based on the employed imaging parameters and an assumed arterial transit time of 1 s for the kidneys [24] . For T1rho, a mono-exponential decay model was fitted pixel-wise using a Levenberg-Marquardt algorithm in OsiriX, on the dataset of 4 TSLs ranging from 10 to 70 ms with a step of 20 ms, using the equation:
To account for signal recovery during the readout echo train, a fully saturated image acquired within the same breath-hold, was subtracted from all T1rho-weighted images before curve fitting.
PC-MRI analysis was performed online after the MRI exam using the manufacturer software package (Argus, Siemens, Germany). A regionof-interest (ROI) was manually drawn on the cross-section of the renal artery on one time frame image, which was then propagated in time and adjusted using the complex difference images. Mean flow velocity was extracted using the phase values in the ROI across the cardiac cycle. The product of the mean flow velocity and cross-sectional area of the renal artery provided estimate of mean global RBF.
Statistical analysis
Regions-of-interest (ROIs) of cortex and medulla were manually drawn by trained researchers on each scan of the 4 MRI modalities on the left and right kidney respectively, using corresponding T1w and T2w MRI (similar slice position) as references (Fig. 2a) . The cortical ROI (C-shape) was drawn along the edge of kidneys and the medullar ROI was defined as wedge shaped islands (N = 2-3) based on low intensity in T1w images and high intensity in T2w images. Care was taken to avoid the high intensity of the pelvis as well as occasional imaging artifacts such as signal dropouts due to B0 inhomogeneity and bSSFP banding artifacts. For BOLD and DWI, ROIs were drawn on the 2 center slices. The mean values of ADC, T2*, T1rho and RBF were extracted from the ROIs and were imported into SPSS (IBM Corp., Armonk, NY, USA) for statistical analysis. The reproducibility of MRI measurements was assessed across the 2 repeated scans using intraclass correlation coefficient (ICC) and within-subject coefficient of variation (wsCV). Bland-Altman (BA) [13] plots were used to show parameter dispersion and the bias and the confidence intervals between the 2 scans for each quantitative MRI parameter. In addition, image quality for each scan of the 4 modalities was evaluated using a 1-4 scale (1 being non-diagnostic, 2 being acceptable, 3 being good, and 4 being excellent).
The 2 repeated scans of each MRI modality were then averaged, as well as values from left and right kidneys. Statistical differences between healthy subjects and LN patients were assessed using unpaired t-test and stepwise binary logistic regression was performed to evaluate the capacity of renal quantitative MRI parameters for the classification of LN and HN groups. Table 2 lists the demographic information and clinical characteristics of the 10 LN patients. The age range and 4:1 female to male ratio were based on the prevalence of LN in women in their thirties. All LN patients underwent renal biopsy within 1 year before MRI with International Society of Nephrology/Renal Pathology Society (ISN/RPS) class 3 to 5 LN (focal, diffuse and membranous fibrosis respectively). All LN and HN subjects had normal estimated glomerular filtration rate (eGFR N 60 mL/min). There was no statistically significant differences of eGFR, age or gender between the LN and HN groups.
Results
Subjects
Image quality assessment
All scans were completed except that PC-MRI acquisition failed 4 times (out of 80) due to gradient interactions with the pulse-oxymetry trigger. Additionally one T1rho and 2 BOLD scans could not be interpreted due to image artifacts. Average image quality was rated good to excellent for all 4 sequences (2.5-3.4, Table 3 ). Figs. 2 and 3 show quantitative ADC, T2*, T1rho and RBF maps of a representative healthy subject and an LN subject respectively, demonstrating excellent image quality for all 4 modalities and negligible registration errors after post-processing with non-rigid motion correction using ANTs.
Test-retest repeatability
All test-retest results are reported in Fig. 4 , separating HN and LN first, and then combining the 2 groups, and finally combining left and right kidneys. For healthy volunteers, all 4 quantitative MRI modalities showed moderate to good (ICC = 0.44-0.88) reproducibility in both the cortex and medulla (Fig. 4a) , except for DWI in the left medulla (ICC = 0.15). The reproducibility was reduced and showed larger variability in LN patients (ICC range 0.12-0.94) with 6 out of 16 measurements below ICC of 0.4: ASL RBF in medulla, T1rho in left cortex, DWI in left cortex and medulla (highlighted in Fig. 3a) . However, ICC for BOLD was increased in LN patients (0.8-0.94) compared to healthy subjects (0.6-0.88). When both HN and LN groups were combined, ICC results were more stabilized (0.17-0.91) with only 2 measurements below ICC of 0.4: T1rho in left cortex (0.38) and DWI in left medulla (0.17). When left and right kidney measurements were further combined (averaged), all 4 quantitative MRI modalities showed moderate to good reproducibility (ICC range 0.42-0.86) except DWI in medulla (ICC = 0.25).
The wsCV were generally below 13% for all 4 modalities across both LN and HN groups (Fig. 4b) , except for ASL RBF in medulla Fig. 2 . Renal anatomical MRI scans (a), and 4 quantitative MRI modalities with repeated scans (b and c) in a healthy volunteer. Each parameter was quantified on both kidneys using regions-of-interest (ROIs) for both the cortex (red) and the medulla (yellow). (wsCV = 18.6-22.7%). Fig. 5 shows the Bland-Altman plots of the 4 quantitative MRI modalities. Estimated BOLD T2* values showed excellent reproducibility (ICC N 0.8, wsCV b 6% for combined LN and HN groups) and clear contrast between the cortex (T2* = 83 ± 8 ms) and medulla (T2* = 60 ± 8 ms). ASL RBF measurements also provided excellent contrast between the cortex (RBF = 325 ± 63 mL/100 g/min) and medulla (RBF = 111 ± 31 mL/100 g/min) with good reproducibility in the cortex (ICC ≥ 0.6, wsCV = 10.9%-11.6%). Medullar RBF showed reduced reproducibility (ICC = 0.46-0.47, wsCV = 20.8-21.1%) probably due to low RBF and signal-to-noise ratio (SNR).
In addition, we found a significant correlation between global mean RBF from PC-MRI and cortical RBF from pCASL (R = 0.53, p = 0.01). PC-MRI was more reproducible in the left renal artery than in the right artery (ICC = 0.86/0.51, wsCV = 21.6%/28.7% for left/right kidney respectively). T1rho provided excellent contrast between the cortex (T1rho = 125 ± 17 ms) and medulla (T1rho = 175 ± 43 ms) with moderate test-retest repeatability (ICC ranging 0.38-0.76, wsCV = 5.9-9.6%). DWI showed poor contrast between the cortex (ADC = 1837 ± 99 × 10 −6 mm 2 /s) and medulla (ADC = 1795 ± 143 × 10 −6 mm 2 /s) with moderate to good reproducibility (ICC = 0.4-0.7, wsCV b 5%) except for left medulla (ICC = 0.17, wsCV = 9.5%). Table 3 lists the mean value and standard deviation (SD) of the 4 qMRI modalities measured in the left and right medulla and cortex of the HN and LN groups respectively. T1rho values measured in the medulla and cortex (both left and right side) were significantly increased in LN patients than in healthy volunteers (205 ± 50 ms vs. 145 ± 15 ms, p b 0.001 in the medulla, 136 ± 20 ms vs. 115 ± 8 ms, p = 0.003 in the cortex). ASL RBF was significantly increased in the right cortex (358 ± 63 mL/min/100 g vs. 295 ± 49 mL/min/100 g, p = 0.046) and in the right medulla (136 ± 32 mL/min/100 g vs. 96 ± 29 mL/min/100 g, p = 0.015). ASL RBF was also increased in the left cortex and medulla but did not reach statistical significance. BOLD and DWI did not show significant differences between LN and HN subjects. The stepwise logistic regression yielded only 1 parameter: medullar T1rho (T1rhom) in the model (χ 2 = 18.398, p b 0.001).
Comparison between HN and LN groups
Using T1rhom, a success rate of 95% for the classification of LN and HN groups was achieved (1 LN patient was mislabeled out of 20 subjects). A receiver operating characteristic (ROC) analysis (Fig. 6 ) yielded a 94% [95% CI: 82%-100%] area under the curve (p = 0.001).
Discussion
The purpose of the present study was to evaluate the test-retest repeatability of a multi-parametric renal quantitative MRI protocol along with its clinical utility in a cohort of healthy volunteers and LN patients. In the whole group of 10 healthy volunteers and 10 LN patients, the reproducibility of the 4 MRI modalities ranged from moderate to good (ICC = 0.4-0.91, wsCV ≤ 12%) with two exceptions (left medullar DWI and left cortical T1rho). As expected, the 4 quantitative MRI techniques were more reliable in healthy volunteers than in LN patients likely due to their variable physical conditions and potentially limited capability for motion control (e.g., breath-holding). The observed repeatability of the 4 qMRI techniques was comparable or slightly better than those reported in literature. For example, the reproducibility of R2* (1/T2*) measurement has been reported to be 3-12% by multiple studies [11, 25, 26] . A recent study reported a wsCV of 18% and 25% for ASL and dynamic contrast-enhanced (DCE) RBF measurement respectively [27] . The estimated MRI parameters (ADC, T2*, RBF and T1rho) in healthy volunteers also match well with reported values in literature for each modality respectively (RBF: [27] , T2*: [26] , ADC: [22] and T1rho: [14] ). In addition, pCASL RBF measurement was validated using global RBF by PC MRI. Overall, our data suggest a reasonable degree of test-retest repeatability and accuracy for the proposed multi-parametric renal qMRI protocol. The employed strategies to control respiratory motion including navigator-gated and breath-hold acquisitions in conjunction with non-rigid motion correction using ANTs were generally successful, resulting in no obvious motion related artifacts in calculated quantitative maps. It is worth noting that ideally test-retest evaluation should be conducted on separate MRI scans on different days. Due to logistic constraints, we performed consecutive scans with patient repositioning in between to assess the repeatability of the qMRI protocol, assuming no changes in subjects' physiological condition. During recent years, noninvasive assessment of renal function using MRI has gained considerable attention [28] . Renal function is characterized by different physiologic aspects, including perfusion, glomerular filtration, interstitial diffusion, tissue oxygenation and fibrosis, which can be assessed using ASL, DCE, DWI, BOLD and T1rho MRI respectively. The present study evaluated 4 non-contrast MRI modalities, and the results showed that T1rho is significantly prolonged in LN patients compared to healthy volunteers, and T1rho in medulla alone yields 95% accuracy for the differentiation between LN and HN groups in the cohort of 20 subjects. The biophysical mechanism underlying T1rho MRI is thought to be related to the proton exchange and dipole-dipole interactions between the free water pool and macromolecules (such as collagen and proteoglycan [29] ). Increased T1rho has been reported in animal models of liver fibrosis with the degree of fibrosis correlated with the degree of increase in T1rho measurements [15] . Chronic kidney disease (CKD) due to LN is characterized by the progressive loss of kidney function resulting from chronic tubulointerstitial injury, which encompasses tubular atrophy and interstitial fibrosis. These renal damages, as well as persistent inflammatory activity, are regarded as major factors leading to the progression of CKD in LN. Increased T1rho in LN patients observed in the present study is consistent with their pathological results showing a variable degree of renal fibrosis (ISN/RPS class 3 to 5). Our data suggest that T1rho is a promising MRI modality for assessing renal function in LN and other kidney diseases, which awaits further clinical evaluation.
ASL RBF was also increased in LN patients compared to healthy volunteers, although statistical significance was only reached for the right kidney. The mechanism for increased RBF in LN patients is not well understood and may reflect inflammatory processes. ASL RBF measurement is emerging as a valuable MRI technique to assess renal function, and has been proposed as an imaging biomarker for renal cell carcinoma [30] . ASL MR studies have estimated renal perfusion at~300 ml/100 g/min for the cortex and~100 ml/100 g/min for the medulla of healthy kidneys [28] . Our data are highly consistent with previous studies, and add support to the validity of using ASL RBF for the characterization of renal function.
Past renal MRI studies have mainly focused on DWI and BOLD which are more clinically available. Significant correlations between ADC, BOLD R2* and GFR measurements as well as pathological findings have been reported in clinical populations with renal diseases [7, 31, 32] . However, controversial findings also exist. In an MRI study on 400 patients with chronic renal diseases at 1.5 and 3 T, no significant differences in R2* of the cortex and medulla were found between patient gender, age, eGFR, or between different stages of chronic kidney disease [33] . As BOLD is sensitive to changes in renal blood flow, blood volume and oxygen metabolism, there may not be a straightforward relationship between BOLD R2* (T2*) measurements and oxygen concentration (hypoxia) or disease stages in renal tissue. DWI is sensitive to the combined effects of microvascular flow and Brownian motion of water molecules within the interstitial space [5, 6] . The estimated ADC values may be variable depending on the model (mono-or bi-exponential) and b values selected for fitting. In the present study, we used b values ≥200 s/mm 2 to minimize the effect of microvascular flow on tissue ADC values [22] . The resultant ADC values (1.8 ± 0.2 × 10 −3 mm 2 /s in the cortex of healthy volunteers) are consistent with literature values of renal tissue ADC [22] . We also conducted bi-exponential fitting based on the IVIM model. However, the resultant perfusion fraction (f%) and pseudo-diffusion (D*) were not stable on a pixel-by-pixel basis. Bi-exponential model fitting was only stable when a fixed pseudodiffusion (D*) value was assumed which may not be plausible for both the cortex and medulla. Our experience suggests that reliable IVIM analysis of renal DWI requires further technical optimization and clinical evaluation.
The choices of the 4 quantitative MRI techniques in the present study were made based on literature evidence of their (potential) sensitivity to renal function as well as scan durations within a clinically manageable time limit. We set the maximum allowed time for each technique to be 3-4 minutes, free breathing or with multiple breath holds. The total duration for the multi-parametric renal qMRI protocol including structural MRI scans was 30-40 min. There are alternative MRI techniques which were not included in our protocol, such as chemical-shift imaging [34] that are not directly related to renal function and MR spectroscopy [35] , for which the duration of acquisition may be prohibitive. There are several limitations of the present study: 1) both ASL and T1rho MRI were single-slice. Recent renal ASL studies have used background suppressed 3D acquisitions to achieve full-kidney coverage, which can be adapted for our techniques [13, 27] . 2) The sample size of 10 LN and 10 HN subjects was relatively small, especially for assessing test-retest repeatability in each group Therefore, our repeatability analysis was mainly based on the combined LN and HN groups. 3) LN patients were all under personalized medication for their condition, with a large panel of medications and medical history. 4) Our study focuses on lupus nephritis and its characterization through parametric MRI. ASL and T1rho remain MRI parameters to be explored in diverse renal pathologies, to evaluate whether they are specific markers of LN and other renal diseases. Finally, the sensitivity and specificity of MRI parameters should be assessed by comparison with the gold standard for the diagnosis of LN-renal biopsy within closely matched time point. Ongoing studies in our lab are correlating qMRI measures with renal biopsy performed within 7 days of MRI in LN subjects. Only after both the accuracy and reproducibility the qMRI measurements are established, multi-parametric qMRI can serve as valid biomarkers in clinical trials of LN.
Conclusion
This study evaluated the test-retest repeatability of a multiparametric renal qMRI protocol including DWI, BOLD, ASL and T1rho MRI along with its clinical utility to differentiate between 10 LN patients and 10 healthy subjects. The reproducibility of the 4 MRI modalities ranged from moderate to good (ICC = 0.4-0.91, wsCV ≤ 12%) with a few exceptions. T1rho and ASL RBF demonstrated significant differences between the LN and HN groups. The value of the multi-parametric renal quantitative MRI protocol to characterize renal structure and function awaits evaluations in larger clinical populations.
Disclosure of Conflict of Interest
This study was sponsored by Biogen Idec. Six co-authors (P-C.C, C.W., A.V., L.B., N.W., J.T.) are employees of Biogen Idec.
